Immunohistochemical staining of the transformed tumor cells of our case expressed positivity for CD 20, CD79a, PAX 5, bcl-2, and bcl-6+, consistent with DLBCL and CD 15 and CD 30 consistent with CHL, similar to the case mentioned above. The gene discussed is BCL2; the disease is neoplasm.